Publication date: Dec 17, 2025
The models estimate which patients face lasting complications and how symptoms may evolve over time. This predictive ability could change clinical care. It also highlighted mitochondrial and metabolic abnormalities that suggest ongoing cellular stress. The researchers found 71 molecular switches that remain active one year after infection. These datasets capture activity across genes, proteins, metabolites, and gene expression. On their own, such datasets overwhelm traditional analysis methods. Recovery rarely follows a straight line, and improvement may stall without warning. Since 2020, about 400 million people worldwide have experienced long COVID. Weeks pass, then months, and symptoms still shape daily life. Fatigue limits movement and breathlessness interrupts routine tasks. Others struggle with shortness of breath, chest discomfort, or cognitive slowing that affects focus and memory. Some develop heart complications or neurological issues that appear months later. Long COVID does not behave like a typical illness.
| Concepts | Keywords |
|---|---|
| Australia | Biological |
| Daily | Body |
| Fibromyalgia | Clinical |
| Professor | Computational |
| Viral | Condition |
| Covid | |
| Identify | |
| Immune | |
| Infection | |
| Long | |
| Models | |
| Molecular | |
| Shape | |
| Symptoms | |
| Traditional |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Coenzyme M |
| drug | DRUGBANK | Etodolac |
| disease | MESH | fibromyalgia |
| disease | MESH | chronic diseases |
| disease | MESH | Spotting |
| disease | MESH | inflammation |
| drug | DRUGBANK | Isoxaflutole |
| disease | MESH | face |
| disease | MESH | breathlessness |
| disease | MESH | Fatigue |
| disease | MESH | infection |
| disease | MESH | long COVID |